|
Volumn 54, Issue 5, 2016, Pages 979-981
|
Confirmation of donor-derived dystrophin in a duchenne muscular dystrophy patient allotransplanted with normal myoblasts
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DEFLAZACORT;
DYSTROPHIN;
EPITOPE;
MONOCLONAL ANTIBODY;
TACROLIMUS;
LEUKOCYTE ANTIGEN;
ACUTE GRAFT REJECTION;
ALLOTRANSPLANTATION;
CELL TRANSPLANTATION;
DUCHENNE MUSCULAR DYSTROPHY;
EXON;
GENE DELETION;
HUMAN;
IMMUNODETECTION;
IMMUNOSUPPRESSIVE TREATMENT;
MUSCLE BIOPSY;
MYOBLAST;
NONHUMAN;
NOTE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
TIBIALIS ANTERIOR MUSCLE;
ADOLESCENT;
DONOR;
FEMALE;
GENETICS;
MALE;
METABOLISM;
PATHOLOGY;
SKELETAL MUSCLE;
TRANSPLANTATION;
ADOLESCENT;
ANTIGENS, CD;
DYSTROPHIN;
EXONS;
FEMALE;
HUMANS;
MALE;
MUSCLE, SKELETAL;
MUSCULAR DYSTROPHY, DUCHENNE;
MYOBLASTS;
TISSUE DONORS;
|
EID: 84991821774
PISSN: 0148639X
EISSN: 10974598
Source Type: Journal
DOI: 10.1002/mus.25129 Document Type: Note |
Times cited : (17)
|
References (7)
|